Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsendocrinology-diabetes-and-growth

Paeds SAQs · endocrinology-diabetes-and-growth

Type 1 diabetes: diagnosis and initial management — formative SAQs

Two formative SAQs on new-onset type 1 diabetes without ketoacidosis: a six-year-old with a two-week history of thirst, polyuria and weight loss who is alert and not acidotic, testing the diagnostic thresholds, the exclusion of ketoacidosis and the first insulin regimen; and an adolescent in whom the type 1 versus type 2 question turns on autoantibodies and C-peptide, plus the honeymoon phase and the rule that insulin is never stopped.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH TheoryABP General Pediatrics
Prompt
Type 1 diabetes: diagnosis and initial management

SAQ 1 — The alert child with new hyperglycaemia (10 marks)

A 6-year-old presents with a two-week history of excessive thirst, frequent urination and a 2 kg weight loss. He is alert, well perfused and tolerating oral fluids. The finger-prick glucose is 22 mmol/L. He has no vomiting, no abdominal pain and normal breathing. This is the classic presentation of new-onset type 1 diabetes without ketoacidosis. [1]

Answer the following

  1. State the criteria by which you can confirm the diagnosis of diabetes in this child. [2]
  2. Describe the single most important assessment you must make before deciding on the treatment pathway, and how you make it. [1]
  3. Outline the initial insulin regimen you would start once ketoacidosis is excluded, including the approximate dose. [3]
  4. List four components of the structured education the family needs before discharge. [3]

Model marking guide

  1. Diabetes is confirmed on glucose: a random plasma glucose of 11.1 mmol/L or higher with classic symptoms (met here at 22 mmol/L), or a fasting plasma glucose of 7.0 mmol/L or higher, or an HbA1c of 48 mmol/mol (6.5 percent) or higher. In a symptomatic child a single high reading is sufficient to diagnose and act. [2]
  2. The critical assessment is to exclude diabetic ketoacidosis, because acidosis diverts the child to a different pathway. Measure capillary or blood ketones together with venous pH and bicarbonate, and assess hydration, conscious level and respiratory pattern. An alert, non-acidotic child with only mildly raised ketones is suitable for the uncomplicated subcutaneous pathway. [1]
  3. Start a subcutaneous basal-bolus regimen: a total daily dose of about 0.5 to 1.0 units per kilogram per day, split roughly half basal (a once or twice daily long-acting analogue) and half bolus (a rapid analogue with each meal), titrated to the glucose pattern. [3]
  4. Any four of: blood glucose monitoring; carbohydrate counting and meal-time dosing; recognition and treatment of hypoglycaemia with fast-acting carbohydrate; sick-day rules built on never stopping insulin; insulin injection technique and site rotation; when and who to contact. [3]
Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References5ShowHide
  1. [1]DiMeglio LA; Evans-Molina C; Oram RA Type 1 diabetes. Lancet, 2018.PMID 29916386
  2. [2]de Bock M; Agwu JC; et al International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets. Horm Res Paediatr, 2024.PMID 39701064
  3. [3]Cengiz E; Danne T; et al International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes. Horm Res Paediatr, 2024.PMID 39884261
  4. [4]Leighton E; Sainsbury CA; Jones GC A Practical Review of C-Peptide Testing in Diabetes. Diabetes Ther, 2017.PMID 28484968
  5. [5]Couper JJ; Haller MJ; et al ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes, 2018.PMID 30051639
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousThyroid nodules, goitre and thyroid cancer — formative SAQsendocrinology-diabetes-and-growthNextType 1 diabetes: insulin therapy, technology and ambulatory care — formative SAQsendocrinology-diabetes-and-growth